Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis

Détails

ID Serval
serval:BIB_5304D37D30B7
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Etude de cas (case report): rapporte une observation et la commente brièvement.
Collection
Publications
Institution
Titre
Chlorpromazine-induced vanishing bile duct syndrome leading to biliary cirrhosis
Périodique
Hepatology
Auteur⸱e⸱s
Moradpour  D., Altorfer  J., Flury  R., Greminger  P., Meyenberger  C., Jost  R., Schmid  M.
ISSN
0270-9139 (Print)
Statut éditorial
Publié
Date de publication
12/1994
Volume
20
Numéro
6
Pages
1437-41
Notes
Case Reports
Journal Article --- Old month value: Dec
Résumé
We describe a 33-yr-old pregnant woman in whom a primary biliary cirrhosis-like syndrome developed after 2 wk of chlorpromazine therapy. The clinical course was characterized by severe jaundice lasting 22 mo, intense pruritus, fever, steatorrhea, high alkaline phosphatase levels and hypercholesterolemia. Jaundice resolved with initiation of ursodeoxycholic acid therapy, but subclinical cholestasis and low-level inflammatory activity persisted and ultimately evolved into biliary cirrhosis. The pathological substrate of this severe and prolonged cholestatic reaction was found to be the vanishing bile duct syndrome with a marked transient pseudoxanthomatosis.
Mots-clé
Adult Bile Ducts/*drug effects/pathology Biopsy Chlorpromazine/*adverse effects Cholestasis/*chemically induced/complications/pathology Female Humans Liver/pathology Liver Cirrhosis, Biliary/*etiology/pathology Pregnancy *Pregnancy Complications Syndrome
Pubmed
Web of science
Création de la notice
25/01/2008 17:06
Dernière modification de la notice
20/08/2019 15:08
Données d'usage